Cerevel Therapeutics Hldg
(NASDAQ:CERE)
$27.80
-0.71[-2.49%]
At close: Nov 28(Delayed 15-Minutes)
Get Real Time Here
$27.80
After Hours: 4:02PM EDT
Day Range27.6 - 29.1252 Wk Range19.86 - 41.46Open / Close28.46 / 27.8Float / Outstanding46.3M / 156.3M
Vol / Avg.341.6K / 576.4KMkt Cap4.3BP/E-50d Avg. Price27.8
Div / Yield-Payout Ratio-Total Float46.3MEPS-0.66

Cerevel Therapeutics Hldg Stock (NASDAQ:CERE), Quotes and News Summary

Cerevel Therapeutics Hldg Stock (NASDAQ: CERE) stock price, news, charts, stock research, profile.

Loading...
Day Range27.6 - 29.1252 Wk Range19.86 - 41.46Open / Close28.46 / 27.8Float / Outstanding46.3M / 156.3M
Vol / Avg.341.6K / 576.4KMkt Cap4.3BP/E-50d Avg. Price27.8
Div / Yield-Payout Ratio-Total Float46.3MEPS-0.66
Seeking Alpha - Jun 26, 2022, 9:40AM
Seeking Alpha - May 10, 2022, 6:34AM
Sector: Health Care.Industry: Biotechnology
Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.620-0.660 -0.0400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Cerevel Therapeutics Hldg (CERE) stock?

A

You can purchase shares of Cerevel Therapeutics Hldg (NASDAQ: CERE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cerevel Therapeutics Hldg's (CERE) competitors?

Q

What is the target price for Cerevel Therapeutics Hldg (CERE) stock?

A

The latest price target for Cerevel Therapeutics Hldg (NASDAQ: CERE) was reported by Mizuho on Thursday, November 10, 2022. The analyst firm set a price target for 28.00 expecting CERE to rise to within 12 months (a possible 0.72% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cerevel Therapeutics Hldg (CERE)?

A

The stock price for Cerevel Therapeutics Hldg (NASDAQ: CERE) is $27.8 last updated November 28, 2022, 9:00 PM UTC.

Q

Does Cerevel Therapeutics Hldg (CERE) pay a dividend?

A

There are no upcoming dividends for Cerevel Therapeutics Hldg.

Q

When is Cerevel Therapeutics Hldg (NASDAQ:CERE) reporting earnings?

A

Cerevel Therapeutics Hldg’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Cerevel Therapeutics Hldg (CERE) going to split?

A

There is no upcoming split for Cerevel Therapeutics Hldg.

Q

What sector and industry does Cerevel Therapeutics Hldg (CERE) operate in?

A

Cerevel Therapeutics Hldg is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.